Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07349459 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completed without a posted recruiting period Eligibility criteria expanded, about 13 words · Site contact updated Show 2 more changesShow less
    • Eligibility criteria expanded, about 13 words
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tanta University
394 trials monitored
See 11 trials at risk
Breast Cancer
5,213 trials monitored
See 271 trials at risk
This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Trial Details
NCT Number NCT07349459
Lead Sponsor Tanta University
Conditions Melatonin, Breast Cancer Patients Diagnosed, Vitamin D Concentration, Doxorubicin
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov